Merck & Co as of Sept. 30, 2025
Portfolio Holdings for Merck & Co
Merck & Co holds 13 positions in its portfolio as reported in the September 2025 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Personalis Ord (PSNL) | 40.2 | $92M | 14M | 6.52 | |
| Moderna (MRNA) | 26.1 | $60M | 2.3M | 25.83 | |
| Kymera Therapeutics (KYMR) | 19.2 | $44M | 772k | 56.60 | |
| Alector (ALEC) | 4.6 | $11M | 3.5M | 2.96 | |
| Entrada Therapeutics | 4.4 | $10M | 1.7M | 5.80 | |
| Evaxion Biotech A/s Sponsored Ads | 2.0 | $4.6M | 1.2M | 3.76 | |
| Sutro Biopharma (STRO) | 1.0 | $2.4M | 2.7M | 0.87 | |
| Miragen Therapeutics (VRDN) | 0.9 | $2.0M | 93k | 21.58 | |
| Lava Therapeutics Nv SHS (LVTX) | 0.8 | $1.8M | 1.1M | 1.56 | |
| Xilio Therapeutics (XLO) | 0.5 | $1.3M | 1.5M | 0.84 | |
| Carisma Therapeutics (CARM) | 0.2 | $404k | 1.5M | 0.27 | |
| Neuphoria Therapeutics (NEUP) | 0.1 | $118k | 10k | 11.79 | |
| Tuhura Biosciences (HURA) | 0.0 | $35k | 14k | 2.48 |
